Suspected myocarditis
2018 Lake Louise criteriaCardiac MRI is the only test that can see myocardial inflammation directly, and it does so by measuring water and by showing where gadolinium lingers. Both signals decay with time from the acute episode, which makes when the scan happens as much a part of the decision as whether it happens.
Chest pain with a raised troponin and unobstructed coronary arteries, new unexplained heart failure or arrhythmia with a suspected inflammatory cause, or follow-up before return to competitive sport.
Referenced decision support — confirm against your local protocol.
Decision support, not a directive. Protocols and timings shown are typical published ones — your local protocol takes precedence, and the vetting radiologist decides.
- Inflamed myocardium holds extra water and has an expanded interstitium, and those two changes are detected by different physics. T2 is dominated by free water, so oedema prolongs it — that is the water-sensitive arm. Native T1 and extracellular volume rise with both oedema and fibrosis, and gadolinium, which cannot enter intact cells, accumulates and washes out slowly wherever the extracellular space is enlarged — that is the tissue-injury arm, seen as late enhancement in a subepicardial or mid-wall distribution rather than the subendocardial pattern of infarction. Requiring one criterion from each arm is what gives the diagnosis its specificity, and it is why omitting mapping to save table time changes the test into a less sensitive one.
Nothing needs resolving before this goes ahead. Routine checks below are owned downstream.
How was this decided?
- pathwayadult — Adults
- rulerule-mr-device-screening — MR safety screening for implants and foreign bodies; checked by Radiographer at the scanner
- rulerule-contrast-reaction-premed — Prior contrast reaction and elective premedication; checked by Nurse before the scan
- rulerule-gadolinium-renal — Kidney function and gadolinium-based contrast; checked by Radiographer at the scanner
- rulerule-paeds-sedation — Sedation or anaesthesia for a child; checked by Nurse before the scan
- rulerule-pregnancy-gadolinium — Gadolinium in known or possible pregnancy; checked by Radiographer at the scanner
- rulerule-iv-access — Intravenous access adequate for the planned injection; checked by Radiographer at the scanner
Decision support only. Local protocol takes precedence.
Handled at the scanner(2)nothing for you to do
Settled and owned downstream. Each returns to a radiologist only on the stated trigger.
- MR safety screening for implants and foreign bodiesComplete the MR safety questionnaire, verify implant labelling and its stated conditions of use against this scanner and this protocol, and ensure no ferromagnetic object enters Zone IV.Radiographer at the scannerBefore the scanFlags back if: An implant or retained foreign body that is MR Unsafe, unlabelled, or cannot be identified; or an MR Conditional device whose stated conditions this scanner or the requested protocol cannot satisfy; or a credible unexcluded intraocular metallic foreign body history.
- Intravenous access adequate for the planned injectionSite and test a cannula that supports the protocol flow rate, preferring an antecubital or large forearm vein, and observe the injection for extravasation. A 20-gauge or larger cannula is preferred for flow rates of 3 mL/s or more.Radiographer at the scannerAt the scannerFlags back if: No cannula can be sited that supports the protocol flow rate — for example only a 22-gauge hand or foot cannula for a CT angiogram needing 4–5 mL/s; or the only available access is a central line or port that is not labelled power-injectable; or an extravasation occurs.
Pathways
Big forks are separate pathways; the first whose conditions match is the one used.
Adults
Matches your inputsDefault| Role | Study & protocol | Why this answers the question |
|---|---|---|
| First line | Cardiac MRI Cardiac MRI — suspected myocarditis usually appropriate | Inflamed myocardium holds extra water and has an expanded interstitium, and those two changes are detected by different physics. T2 is dominated by free water, so oedema prolongs it — that is the water-sensitive arm. Native T1 and extracellular volume rise with both oedema and fibrosis, and gadolinium, which cannot enter intact cells, accumulates and washes out slowly wherever the extracellular space is enlarged — that is the tissue-injury arm, seen as late enhancement in a subepicardial or mid-wall distribution rather than the subendocardial pattern of infarction. Requiring one criterion from each arm is what gives the diagnosis its specificity, and it is why omitting mapping to save table time changes the test into a less sensitive one. |
| First line | Transthoracic echocardiography Transthoracic echocardiography — standard adult study usually appropriate | Echocardiography is the study that happens on the day of presentation and it answers the questions that decide the next few hours rather than the diagnosis: is there a pericardial effusion and is it compromising filling, is ventricular function impaired and by how much, is there a regional wall motion abnormality in a coronary territory that makes this an infarct, and is there a thrombus in a poorly contracting ventricle. Fulminant myocarditis declares itself here, as an acutely impaired and often thickened, oedematous-looking ventricle, and that finding changes the destination to a coronary care unit rather than an MRI list. It is complementary to and not competing with cardiac MRI: echo cannot see inflammation, and a completely normal echo does not exclude myocarditis — which is precisely why the MRI request survives it. |
| Second line | CT Coronary Angiogram (CCTA) CT Coronary Angiogram — ECG-Synchronised | Myocarditis is often a diagnosis of exclusion in a patient with chest pain and a raised troponin, and the exclusion that must be made first is obstructive coronary disease. Where invasive angiography has not been performed, CT angiography does this non-invasively and can be arranged quickly — and a normal study is what converts the presentation into the myocarditis pathway. |
Pitfalls
- Scheduling the scan weeks after the acute episode. Oedema resolves, the water-sensitive criterion turns negative, and a genuinely myocarditic patient is reported as showing only non-specific scar.
- Accepting a protocol with late enhancement but no oedema-sensitive mapping — it reverts to an older, less sensitive diagnostic standard.
- Applying mapping thresholds from a different scanner, field strength or vendor.
- Mistaking subendocardial or transmural enhancement for myocarditis. That distribution follows a coronary territory and is infarction until proven otherwise.
- Poor gating in an arrhythmic patient, which degrades exactly the sequences the diagnosis depends on — rate and rhythm should be checked before the appointment is issued.
- Forgetting cardiac sarcoidosis, which uses the same toolkit, produces a similar pattern, and has an entirely different treatment.
Priors — what to pull first
- Note the date of any previous cardiac MRI. Residual mid-wall enhancement months later is scar, not active inflammation, and the distinction is made by the mapping and oedema sequences rather than by the enhancement itself.
- Where the question is fitness to return to sport, the comparator study is what makes resolution demonstrable.
What makes a good request
- A good request gives the date of symptom onset, the troponin trend, whether coronary disease has already been excluded and how, the rhythm, and any device.
- The diagnostic framework combines a water-sensitive criterion with a fibrosis- or expansion-sensitive one, so the protocol needs both oedema-sensitive imaging and late enhancement. A study with late enhancement alone under-calls acute inflammation.
- Mapping values are specific to the field strength, the vendor and the sequence, and are meaningless without the local reference range — which is why a value quoted from another centre cannot be reused.
Scoring this once it is done
The classification and risk tools this question ends in.
How these studies are acquired
Contrast, phases and timing for every study on the pathways above.
Confirm locally
- Cardiac MRI — suspected myocarditis: timings are typical — confirm against local protocol.
- Timings, contrast volumes and rates above are typical published values. Your department's protocol, scanner and patient population decide the actual numbers.
- Safety thresholds and premedication policy follow local policy where it differs from the cited guidance.
References
- Comparison of original and 2018 Lake Louise criteria for diagnosis of acute myocarditis · Primary literature
- Multiparametric CMR in acute myocarditis with endomyocardial biopsy confirmation · Primary literature
- 2023 ESC Guidelines for the management of cardiomyopathies · Other
- American College of Radiology Manual on MR Safety: 2024 Update and Revisions. Radiology. · ACR MR Safety
- ACR Manual on MR Safety — zoning, MR Safe / MR Conditional / MR Unsafe labelling, and screening of patients and personnel · ACR MR Safety
- Safety of MRI in patients with cardiac implantable electronic devices — conditions of use, device interrogation and monitoring · Primary literature
- ACR Manual on Contrast Media — premedication regimens (elective oral prednisone 50 mg at 13/7/1 h plus diphenhydramine 50 mg at 1 h; methylprednisolone 32 mg at 12 and 2 h; accelerated IV hydrocortisone 200 mg or methylprednisolone 40 mg every 4 h; regimens under 4–5 h lack evidence of efficacy) · ACR Contrast Manual
- Management and Prevention of Hypersensitivity Reactions to Radiocontrast Media: A Consensus Statement from the ACR and the AAAAI. J Allergy Clin Immunol Pract, 2025. · Primary literature
- Schabelman E, Witting M. The relationship of radiocontrast, iodine and seafood allergies: a medical myth exposed. J Emerg Med. · Primary literature
- CAR/CSACI Practice Guidance for Contrast Media Hypersensitivity (2025) · Other
- Weinreb JC, Rodby RA, Yee J, Wang CL, Fine D, McDonald RJ, Perazella MA, Dillman JR, Davenport MS. Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease: Consensus Statements from the ACR and the National Kidney Foundation. — Group II NSF risk: 0 events in 4931 administrations at eGFR <30; upper 95% CI bounds 0.07% overall, 0.2% CKD 5D, 0.5% CKD 5 non-dialysis · ACR/NKF consensus
- Woolen SA et al. Risk of NSF in patients with stage 4 or 5 CKD receiving a group II GBCA: systematic review and meta-analysis. JAMA Intern Med. · Primary literature
- ESUR Contrast Media Guidelines v10.0 — gadolinium agents and NSF risk classification — European practice diverges: after the EMA Article 31 referral the marketing authorisations of several intravenous linear agents (gadodiamide, gadopentetate, gadoversetamide) were suspended, so the ACR "group I" discussion is largely moot in the EU/UK while remaining live in the US · ESUR
- EMA — gadolinium-containing contrast agents Article 31 referral: PRAC confirms restrictions on linear agents · Other
- AAP/AAPD Guidelines for Monitoring and Management of Pediatric Patients Before, During, and After Sedation for Diagnostic and Therapeutic Procedures. Pediatrics 2019;143(6):e20191000. · Other
- Sedation and anaesthesia for imaging of the infant and neonate — a brief review (feed-and-wrap, fasting, monitoring) · Primary literature
- Image Gently — reducing the need for sedation through preparation and faster protocols in paediatric imaging · Image Gently
- Contrast Media in Pregnant and Lactating Patients — AJR Special Series on Contrast Media · Primary literature
- ACOG Committee Opinion — Guidelines for Diagnostic Imaging During Pregnancy and Lactation · Other
- ACR-SPR Practice Parameter for the Use of Intravascular Contrast Media · Other
- Behrendt FF et al. Peripheral intravenous power injection of iodinated contrast media through 22G and 20G cannulas: can high flow rates be achieved safely? A clinical feasibility study. · Primary literature
- Pressure injectors for radiologists: a review — extravasation incidence and catheter/flow-rate relationships · Primary literature
Implemented from the cited published sources. Educational and workflow support only; confirm against current guidelines and local policy before clinical use.